A randomized clinical trial comparing metabolic parameters after 48 weeks of standard- and low-dose stavudine therapy and tenofovir disoproxil fumarate therapy in HIV-infected South African patients

Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Studya

(2013) L. Ryom et al.   JOURNAL OF INFECTIOUS DISEASES

The early effects of stavudine compared with tenofovir on adipocyte gene expression, mitochondrial DNA copy number and metabolic parameters in South African HIV-infected patients: a randomized trial

(2012) CN Menezes et al.   HIV MEDICINE

A longitudinal study of stavudine-associated toxicities in a large cohort of South African HIV infected subjects

(2011) Colin N Menezes et al.   BMC INFECTIOUS DISEASES

The Pathophysiology of HIV-/HAART-Related Metabolic Syndrome Leading to Cardiovascular Disorders: The Emerging Role of Adipokines

(2011) John Palios et al.   Experimental Diabetes Research

Body fat redistribution and metabolic abnormalities in HIV-infected patients on highly active antiretroviral therapy: novel insights into pathophysiology and emerging opportunities for treatment

(2010) Faidon Magkos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial

(2009) Alexandra Calmy et al.   AIDS

Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy

(2009) ET Overton et al.   HIV MEDICINE

Cost and Cost-Effectiveness of Switching From Stavudine to Tenofovir in First-Line Antiretroviral Regimens in South Africa

(2009) Sydney Rosen et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Association of C-Reactive Protein and HIV Infection With Acute Myocardial Infarction

(2009) Virginia A Triant et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Hypoadiponectinemia in lipodystrophic HIV individuals: A metabolic marker of subclinical cardiac damage

(2009) G.P. Bezante et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda

(2009) Johan van Griensven et al.   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE

Effect of Reducing the Dose of Stavudine on Body Composition, Bone Density, and Markers of Mitochondrial Toxicity in HIV‐Infected Subjects: A Randomized, Controlled Study

(2008) G. A. McComsey et al.   CLINICAL INFECTIOUS DISEASES

Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study

(2008) S. De Wit et al.   DIABETES CARE

Association of HIV Infection and HIV/HCV Coinfection With C-Reactive Protein Levels

(2008) Jason S Reingold et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES